© 2020 MJH Life Sciences and Psychiatric Times. All rights reserved.
March 01, 2004
Cognitive deficits, which play a crucial role in the pathogenesis and prognosis of schizophrenia, can lead to noncompliance and poor outcomes. New treatment options need to be tested that may offer surplus effects on neurocognition.